Orionis and Genentech link on oncology small-molecule glue medicines

Orionis Biosciences has announced a multi-year partnership with Roche’s Genentech for small-molecule monovalent glue medicine.

May 22, 2025 - 06:00
Orionis and Genentech link on oncology small-molecule glue medicines
Orionis Biosciences has announced a multi-year partnership with Roche’s Genentech for small-molecule monovalent glue medicine.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow